Guest post by Rory Horner (University of Manchester) and Ken Shadlen (LSE) Various UK media reports have blamed lower than expected supply of the AstraZeneca vaccine from India for a slowing of the UK’s vaccination programme, especially delaying immunisation of the under-50s. Although five million doses of vaccines produced by the Serum Institute of India were dispatched from India to